APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,510,331 | +10.7% | 92,280 | +165.2% | 0.01% | 0.0% |
| Q2 2023 | $3,169,916 | +50.5% | 34,796 | +9.0% | 0.01% | +80.0% |
| Q1 2023 | $2,105,707 | -34.8% | 31,924 | -48.9% | 0.01% | -50.0% |
| Q4 2022 | $3,231,875 | +15.4% | 62,500 | +52.4% | 0.01% | +11.1% |
| Q3 2022 | $2,801,000 | +4.6% | 41,000 | -30.7% | 0.01% | 0.0% |
| Q2 2022 | $2,677,000 | +71.1% | 59,200 | +92.1% | 0.01% | +80.0% |
| Q1 2022 | $1,565,000 | -31.5% | 30,818 | -55.5% | 0.01% | -37.5% |
| Q3 2021 | $2,284,000 | +55.8% | 69,300 | +198.8% | 0.01% | +33.3% |
| Q2 2021 | $1,466,000 | +53.7% | 23,196 | -20.6% | 0.01% | 0.0% |
| Q2 2020 | $954,000 | +56.7% | 29,225 | +28.7% | 0.01% | +50.0% |
| Q1 2020 | $609,000 | +6.3% | 22,708 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $573,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |